Scholarlink

Purpose of Review <p>Lung cancer, particularly non-small cell lung cancer, remains the leading cause of cancer-related mortality worldwide. Despite advances in therapy, limitations such as late diagnosis, toxicity, and drug resistance necessitate alternative strategies. This review aims to highlight the emerging role of medicinal plant seeds and their phytochemicals as potential anticancer agents against NSCLC.</p> Recent Findings <p>Seeds from <i>Nigella sativa</i>, <i>Vitis vinifera</i>, <i>Sesamum indicum</i>, <i>Coix lacryma-jobi</i>, <i>Trigonella foenum-graecum</i>, <i>Artocarpus heterophyllus</i>, <i>Citrullus lanatus</i>, and <i>Linum usitatissimum</i> demonstrate anticancer activity in preclinical lung cancer models. Their bioactive compounds, extracts, oils, and nanoparticle formulations induce apoptosis, arrest the cell cycle, inhibit angiogenesis and metastasis, modulate oxidative stress, and suppress epithelial-mesenchymal transition. These effects are mediated by key pathways including EGFR, PI3K/Akt, NF-κB, Nrf2, and caspase signaling. Compounds such as sesamol, diosgenin, and grape seed procyanidins have shown potential in enhancing chemotherapeutic outcomes and overcoming drug resistance, particularly through nanoformulation-based delivery systems.</p> Summary <p> Medicinal plant seeds exhibit multi-targeted mechanisms and represent promising candidates for lung cancer therapy. Further translational and clinical studies are essential to establish their efficacy and integration into lung cancer management.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Medicinal Plant Seeds in Nutritional Oncology: An Integrative Review of Emerging Therapeutics for Non-Small Cell Lung Cancer

  • 期刊论文

  • 发表日期：

    2026年3月20日

查看全文
  • Gajavarthini Senthilkumar,
  • Renuka Saravanan,
  • Sivakumar Ramalingam

摘要

Purpose of Review

Lung cancer, particularly non-small cell lung cancer, remains the leading cause of cancer-related mortality worldwide. Despite advances in therapy, limitations such as late diagnosis, toxicity, and drug resistance necessitate alternative strategies. This review aims to highlight the emerging role of medicinal plant seeds and their phytochemicals as potential anticancer agents against NSCLC.

Recent Findings

Seeds from Nigella sativa, Vitis vinifera, Sesamum indicum, Coix lacryma-jobi, Trigonella foenum-graecum, Artocarpus heterophyllus, Citrullus lanatus, and Linum usitatissimum demonstrate anticancer activity in preclinical lung cancer models. Their bioactive compounds, extracts, oils, and nanoparticle formulations induce apoptosis, arrest the cell cycle, inhibit angiogenesis and metastasis, modulate oxidative stress, and suppress epithelial-mesenchymal transition. These effects are mediated by key pathways including EGFR, PI3K/Akt, NF-κB, Nrf2, and caspase signaling. Compounds such as sesamol, diosgenin, and grape seed procyanidins have shown potential in enhancing chemotherapeutic outcomes and overcoming drug resistance, particularly through nanoformulation-based delivery systems.

Summary

Medicinal plant seeds exhibit multi-targeted mechanisms and represent promising candidates for lung cancer therapy. Further translational and clinical studies are essential to establish their efficacy and integration into lung cancer management.

Graphical Abstract